Patient Guide: FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTFX-909-CLINPRO-1
Status: ACTIVE_NOT_RECRUITING
Condition: Advanced Urothelial Cancer, Advanced Solid Tumours
Phase: PHASE1

Loading interactive enrollment tools...

The full interactive experience will load momentarily